PDF herunterladen
Thromb Haemost 1997; 78(02): 852-854
DOI: 10.1055/s-0038-1657640
Rapid Communication
Schattauer GmbH Stuttgart

Heat Stability of Two Candidate International Reference Preparations for Recombinant Human Tissue Factor

A M H P van den Besselaar
1   The Haemostasis and Thrombosis Research Centre, Department of Haematology, University Hospital Leiden, The Netherlands
,
C J J van Rijn
1   The Haemostasis and Thrombosis Research Centre, Department of Haematology, University Hospital Leiden, The Netherlands
,
D A Taberner
2   The Thrombosis Reference Centre, Withington Hospital, Manchester, UK
,
L J Goodman
2   The Thrombosis Reference Centre, Withington Hospital, Manchester, UK
,
L Poller
3   The Department of Pathological Sciences, The University of Manchester, Manchester, UK
,
K Clarke
3   The Department of Pathological Sciences, The University of Manchester, Manchester, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 12. 1996

Accepted after revision 26. März 1997

Publikationsdatum:
12. Juli 2018 (online)

  als PDF herunterladen  Lizenzen und Reprints

Summary

Adequate heat stability of international reference preparations (IRP) for thromboplastin (tissue factor) is an essential requirement. Accelerated degradation testing was performed by three laboratories on two candidate IRP for recombinant human tissue factor.

Heat treatment of these candidates resulted in slight shortening of the PT, contrasting with heat-induced prolongation of the PT observed with a conventional human brain derived IRP.

Heat stability of these candidates was improved when compared with the stability of previous recombinant human tissue factor preparations.

The PT-ratio did not change significantly when the candidates were stored for 28 days at 44° C. It’ can therefore be concluded that both candidates are acceptable with regard to stability.

 

  • References

  • 1 Kirkwood TBL. Predicting the stability of biological standards and products. Biometrics 1977; 33: 736-742
    CrossrefPubMedGoogle Scholar
  • 2 Bangham DR, Biggs R, Brozovic M, Denson KWE. Draft report of a collaborative study of two thromboplastins including the use of common abnormal plasma. Thromb Diathes Haemorrh 1970; suppl. 40: 341-351
    PubMedGoogle Scholar
  • 3 Van denBesselaar AMHP, Loeliger EA, Bertina RM. Stability of reference thromboplastin. In: Standardization of Coagulation Assays: An Overview. Triplett DA. (ed). College of American Pathologists, Skokie, Illinois 1982. pp. 69-79
    Google Scholar
  • 4 WHO Expert Committee on Biological Standardization. Thirty-third Report. WHO Tech Rep Ser 1983; 687: 81-105
    PubMedGoogle Scholar
  • 5 Tripodi A, Poller L, Van den BesselaarAMHP, Mannucci PM. A proposed scheme for calibration of international reference preparations of thromboplastin for the prothrombin time. Thromb Haemost 1995; 74: 1368-1369
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 6 Tripodi A. Replacement of WHO Human Thromboplastin. Report of the SSC/ISTH Subcommittee on Control of Anticoagulation. June 23 1996. Barcelona:
    Google Scholar
  • 7 Geigy Wissenschaftliche Tabellen, Teilband Statistik, 8. Auflage. 1980. p. 218 Ciba-Geigy AG; Basel:
    Google Scholar
  • 8 Van den BesselaarAMHP, Witteveen E, Schaefer-van Mansfeld H, Meeuwisse-Braun J, Strebus A. Accelerated degradation test of lyophilized recombinant tissue factor-liposome preparations. Thromb Haemost 1995; 73: 392-397
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253). Thromb Haemost 1984; 52: 336-342
    Artikel in Thieme ConnectPubMedGoogle Scholar